Lite Strategy, Inc. Class of Warrant or Right, Outstanding
Lite Strategy, Inc. (LITS) had Class of Warrant or Right, Outstanding of 3.95 million shares as of 2026-03-31, per its 10-Q filed 2026-05-13.
Financial Statements › Notes
us-gaap:ClassOfWarrantOrRightOutstanding · last filed 2026-05-13
- 2026-03-31: Class of Warrant or Right, Outstanding 3.95M shares.
- 2025-12-31: Class of Warrant or Right, Outstanding 3.95M shares.
- 2025-09-30: Class of Warrant or Right, Outstanding 4.85M shares.
- 2016-09-30: Class of Warrant or Right, Outstanding 215.72K shares.
| Period end | Class of Warrant or Right, Outstanding |
|---|---|
| 2026-03-31 | 3.95M shares 10-Q · filed 2026-05-13 |
| 2025-12-31 | 3.95M shares 10-Q · filed 2026-02-17 |
| 2025-09-30 | 4.85M shares 10-Q · filed 2025-11-14 |
| 2016-09-30 | 215.72K shares 10-Q · filed 2016-11-09 |
| 2013-06-30 | 768.00 shares 10-K · filed 2013-09-18 |
| 2013-03-31 | 4.60M shares 10-Q · filed 2013-05-09 |
| 2012-12-31 | 4.64M shares 10-Q · filed 2013-02-12 |
| 2012-09-30 | 4.61K shares 10-Q · filed 2012-11-13 |
| 2012-06-30 | 248.00K shares 10-K · filed 2012-09-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |